Skip to content
Screener

Ultralife ULBI Q4 2025 Annual earnings

Reported March 10, 2026 · Before market open

Revenue$48.5MMiss by $8.5M
EPS$0.12Miss by $0.12
Revenue estimate$57.0M
EPS estimate$0.24

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$56.0M
EPS estimate$0.23

Financials

Q4 2025

Income statement

See full
Revenue$48.5M+10.6%
Gross profit$11.5M+8.8%
Operating income-$1.5M-159%
Net income-$1.5M-193%
EPS (diluted)-$8.75-192%

Balance sheet

See full
Cash & equivalents$9.3M+36.3%
Total debt$53.0M-9.3%
Total equity$130.0M-3.0%
Total assets$216.9M-1.6%

Cash flow

See full
Operating cash flow$1.5M-51.1%
CapEx$882.0K+45.5%
Free cash flow$607.0K-75.1%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$95.23M-23.1%
Enterprise value$138.87M-20.8%
P/S0.5×-0.3×

Profitability

See full
Gross margin24.1%-1.7pp
Operating margin-3.1%-9.1pp
Net margin-3.1%-6.9pp

Returns & leverage

See full
Return on equity-4.5%-9.3pp
Debt / equity0.4×0.0×
Current ratio2.8×-0.5×

Segments

By segment

See full
Battery Energy Products$45.9M+15.1%
Communications Systems$2.6M-35.2%

FAQ

When did Ultralife report Q4 2025 earnings?
Ultralife (ULBI) reported Q4 2025 earnings on March 10, 2026 before market open.
What were Ultralife's Q4 2025 revenue and EPS?
Ultralife reported revenue of $48.5M and eps of $0.12 for Q4 2025.
Did Ultralife beat estimates in Q4 2025?
Revenue missed the consensus estimate of $57.0M by $8.5M. EPS missed the consensus estimate of $0.24 by $0.12.
How did Ultralife's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 10.6% from $43.9M a year earlier and eps declined 33.3% from $0.18.
Where can I find Ultralife's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001437749-26-007567) and the 10-K periodic report (0001437749-26-009385) directly on SEC EDGAR. The filing index links above go to sec.gov.